Femtosecond laser systems superior to microkeratome system

Article

Flap creation for bilateral LASIK is best performed using an IntraLase, VisuMax or Femto LDV, rather than a microkeratome.

An investigation featured in the Journal of Cataract and Refractive Surgery shows flap creation for bilateral LASIK is best performed using an IntraLase, VisuMax or Femto LDV, rather than a microkeratome.

A team led by Dr Hyunseok Ahn, Department of Ophthalmology, Institute of Vision and Research, Yonsei University College of Medicine, Seoul, South Korea, evaluated the thickness and side-cut angle of LASIK flaps made by 1 of 3 femtosecond lasers or an M2 microkeratome, using a RtVue Fourier–domain OCT.

The participants were split into 3 femtosecond laser groups and 1 microkeratome group. Femtosecond laser group 1 (Intralase) consisted of 50 eyes, group 2, 40 eyes (VisuMax), group 3, 64 eyes (Femto LDV) and the microkeratome group consisted of 52 eyes. Groups 1 and 2 had fairly even flap configuration. Group 3 and 4 had a meniscus shape, with group 3 having the greatest flap thickness predictability.

All three of the femtosecond laser systems performed better than the microkeratome system in general. The IntraLase's side-cut angle was closest to 90º and had the least difference between central flap thickness and the mean peripeheral. The femtosecond laser systems were also able to produce a variety of flap configurations depending on the each mechanism.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.